Fox Chase Cancer Center

Penn Medicine Biobank Return of Results Program

CollaboratorNo phaseActive, not recruiting20232,500 people19 Oct 2023clinicaltrials.gov

NCT04379999

Early phase 1Completed201843 people8 May 2020clinicaltrials.gov

NCT03114527

Phase 2Active, not recruiting201748 people14 Apr 2017clinicaltrials.gov

NCT02710734

Phase 2Completed201678 people17 Mar 2016clinicaltrials.gov

NCT02614859

Phase 2Completed201529 people25 Nov 2015clinicaltrials.gov

NCT02539459

Phase 2Terminated201520 people3 Sept 2015clinicaltrials.gov

NCT02050009

Phase 1Withdrawn0 people30 Jan 2014clinicaltrials.gov

NCT01637194

Phase 1Completed200812 people11 Jul 2012clinicaltrials.gov

NCT01611662

Phase 2Terminated201232 people5 Jun 2012clinicaltrials.gov

NCT01539174

Phase 2Withdrawn0 people27 Feb 2012clinicaltrials.gov

NCT01332279

Phase 1Withdrawn20110 people11 Apr 2011clinicaltrials.gov

NCT01281514

Phase 1Completed201021 people24 Jan 2011clinicaltrials.gov

NCT01208662

CollaboratorPhase 3Active, not recruiting2010729 people24 Sept 2010clinicaltrials.gov

NCT01031420

Phase 2Completed200954 people14 Dec 2009clinicaltrials.gov

NCT00694291

Phase 2Withdrawn20080 people10 Jun 2008clinicaltrials.gov

NCT00365508

Phase 4Completed2006642 people17 Aug 2006clinicaltrials.gov

NCT00101335

Phase 2Completed200310 Jan 2005clinicaltrials.gov

NCT00003263

Phase 1Completed19966 people13 Sept 2004clinicaltrials.gov

NCT00021359

Phase 2Completed199917 people11 Mar 2004clinicaltrials.gov

NCT00003264

Phase 2Completed199722 people1 Mar 2004clinicaltrials.gov